Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Alpha Amino Acid Ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel water-based method for C-N bond construction eliminates metal catalysts, offering green, scalable routes for pharmaceutical intermediates.
Novel one-pot method replaces Pd catalysis for EGFR inhibitor intermediates, offering cost-effective scale-up and high purity for pharma supply chains.
Patent CN111057735B details a novel esterase route for high-purity chiral intermediates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN112279743B details a novel iridium-catalyzed asymmetric hydrogenation method for chiral alpha-amino acid esters, offering high enantioselectivity and industrial scalability for pharmaceutical intermediates.
Patent CN113582865A details a novel copper-catalyzed route for alpha,alpha-disubstituted chiral amino acid esters, offering high enantioselectivity and streamlined manufacturing for API intermediates.
Patent CN102993065B details a novel Lewis acid-catalyzed route for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN108948077B details a green cobalt-catalyzed synthesis of alpha-phosphorylated amino acid esters using air oxidation, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN102675135A details a mild, high-yield method for synthesizing alpha-amino acid esters using triethylamine catalysis, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN106831474B reveals a one-step rhodium-catalyzed synthesis for anticancer intermediates, offering significant cost and supply chain advantages for global pharmaceutical manufacturers.
Novel palladium-catalyzed route for alpha-amino acid esters using alkenyl ethers. Offers mild conditions and high atom economy for pharmaceutical intermediate manufacturing.
Novel Ni-catalyzed asymmetric synthesis offers high yield and enantioselectivity for pharmaceutical intermediates, ensuring supply chain stability.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
Patent CN112920066A reveals a novel palladium-catalyzed route for alpha-amino acid esters, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Novel Ni-catalyzed asymmetric method for chiral quaternary carbon alpha-amino acid esters. High yield, excellent ee, scalable process for API intermediates.